A compound screen performed by Krstic et al. revealed that NB cells are vulnerable to various classes of epigenetic regulators, and they showed that C646, a CBP/p300 HAT inhibitor, is specifically effective in reducing the viability of NB cells with MNA [163]. Here, TMPRSS11D is linked to neuroblastoma.